Mutations in the p53 gene occur in diverse human tumour types

Janice M. Nigro, Suzanne J. Baker, Antonette C. Preisinger, J. Milburn Jessup, Richard Hosteller, Karen Cleary, Sandra H. Bigner, Nancy Davidson, Stephen B Baylin, Peter Devilee, Thomas Glover, Francis S. Collins, Ainsley Weslon, Rama Modali, Curtis C. Harris, Bert Vogelstein

Research output: Contribution to journalArticle

Abstract

THE p53 gene has been a constant source of fascination since its discovery nearly a decade ago1,2. Originally considered to be an oncogene, several convergent lines of research have indicated that the wild-type gene product actually functions as a tumour suppressor gene3-9. For example, expression of the neoplastic phenotype is inhibited, rather than promoted, when rat cells are transfected with the murine wild-type p53 gene together with mutant p53 genes and/or other oncogenes3,4. Moreover, in human tumours, the short arm of chromosome 17 is often deleted (reviewed in ref. 10). In colorectal cancers, the smallest common region of deletion is centred at 17pl3.1 (ref. 9); this region harbours the p53 gene, and in two tumours examined in detail, the remaining (non-deleted) p53 alleles were found to contain mutations9. This result was provocative because allelic deletion coupled with mutation of the remaining allele is a theoretical hallmark of tumour-suppressor genes11. In the present report, we have attempted to determine the generality of this observation; that is, whether tumours with allelic deletions of chromosome 17p contain mutant p53 genes in the allele that is retained. Our results suggest that (1) most tumours with such allelic deletions contain p53 point mutations resulting in amino-acid substitutions, (2) such mutations are not confined to tumours with allelic deletion, but also occur in at least some tumours that have retained both parental 17p alleles, and (3) p53 gene mutations are clustered in four 'hot-spots' which exactly coincide with the four most highly conserved regions of the gene. These results suggest that p53 mutations play a role in the development of many common human malignancies.

Original languageEnglish (US)
Pages (from-to)705-708
Number of pages4
JournalNature
Volume342
Issue number6250
StatePublished - 1989

Fingerprint

p53 Genes
Mutation
Neoplasms
Alleles
Chromosome Deletion
Chromosomes, Human, Pair 17
Amino Acid Substitution
Oncogenes
Point Mutation
Genes
Colorectal Neoplasms
Phenotype

ASJC Scopus subject areas

  • General

Cite this

Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., ... Vogelstein, B. (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature, 342(6250), 705-708.

Mutations in the p53 gene occur in diverse human tumour types. / Nigro, Janice M.; Baker, Suzanne J.; Preisinger, Antonette C.; Jessup, J. Milburn; Hosteller, Richard; Cleary, Karen; Bigner, Sandra H.; Davidson, Nancy; Baylin, Stephen B; Devilee, Peter; Glover, Thomas; Collins, Francis S.; Weslon, Ainsley; Modali, Rama; Harris, Curtis C.; Vogelstein, Bert.

In: Nature, Vol. 342, No. 6250, 1989, p. 705-708.

Research output: Contribution to journalArticle

Nigro, JM, Baker, SJ, Preisinger, AC, Jessup, JM, Hosteller, R, Cleary, K, Bigner, SH, Davidson, N, Baylin, SB, Devilee, P, Glover, T, Collins, FS, Weslon, A, Modali, R, Harris, CC & Vogelstein, B 1989, 'Mutations in the p53 gene occur in diverse human tumour types', Nature, vol. 342, no. 6250, pp. 705-708.
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hosteller R, Cleary K et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342(6250):705-708.
Nigro, Janice M. ; Baker, Suzanne J. ; Preisinger, Antonette C. ; Jessup, J. Milburn ; Hosteller, Richard ; Cleary, Karen ; Bigner, Sandra H. ; Davidson, Nancy ; Baylin, Stephen B ; Devilee, Peter ; Glover, Thomas ; Collins, Francis S. ; Weslon, Ainsley ; Modali, Rama ; Harris, Curtis C. ; Vogelstein, Bert. / Mutations in the p53 gene occur in diverse human tumour types. In: Nature. 1989 ; Vol. 342, No. 6250. pp. 705-708.
@article{a97f9ce7244844969f90f57f1c41e3f0,
title = "Mutations in the p53 gene occur in diverse human tumour types",
abstract = "THE p53 gene has been a constant source of fascination since its discovery nearly a decade ago1,2. Originally considered to be an oncogene, several convergent lines of research have indicated that the wild-type gene product actually functions as a tumour suppressor gene3-9. For example, expression of the neoplastic phenotype is inhibited, rather than promoted, when rat cells are transfected with the murine wild-type p53 gene together with mutant p53 genes and/or other oncogenes3,4. Moreover, in human tumours, the short arm of chromosome 17 is often deleted (reviewed in ref. 10). In colorectal cancers, the smallest common region of deletion is centred at 17pl3.1 (ref. 9); this region harbours the p53 gene, and in two tumours examined in detail, the remaining (non-deleted) p53 alleles were found to contain mutations9. This result was provocative because allelic deletion coupled with mutation of the remaining allele is a theoretical hallmark of tumour-suppressor genes11. In the present report, we have attempted to determine the generality of this observation; that is, whether tumours with allelic deletions of chromosome 17p contain mutant p53 genes in the allele that is retained. Our results suggest that (1) most tumours with such allelic deletions contain p53 point mutations resulting in amino-acid substitutions, (2) such mutations are not confined to tumours with allelic deletion, but also occur in at least some tumours that have retained both parental 17p alleles, and (3) p53 gene mutations are clustered in four 'hot-spots' which exactly coincide with the four most highly conserved regions of the gene. These results suggest that p53 mutations play a role in the development of many common human malignancies.",
author = "Nigro, {Janice M.} and Baker, {Suzanne J.} and Preisinger, {Antonette C.} and Jessup, {J. Milburn} and Richard Hosteller and Karen Cleary and Bigner, {Sandra H.} and Nancy Davidson and Baylin, {Stephen B} and Peter Devilee and Thomas Glover and Collins, {Francis S.} and Ainsley Weslon and Rama Modali and Harris, {Curtis C.} and Bert Vogelstein",
year = "1989",
language = "English (US)",
volume = "342",
pages = "705--708",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6250",

}

TY - JOUR

T1 - Mutations in the p53 gene occur in diverse human tumour types

AU - Nigro, Janice M.

AU - Baker, Suzanne J.

AU - Preisinger, Antonette C.

AU - Jessup, J. Milburn

AU - Hosteller, Richard

AU - Cleary, Karen

AU - Bigner, Sandra H.

AU - Davidson, Nancy

AU - Baylin, Stephen B

AU - Devilee, Peter

AU - Glover, Thomas

AU - Collins, Francis S.

AU - Weslon, Ainsley

AU - Modali, Rama

AU - Harris, Curtis C.

AU - Vogelstein, Bert

PY - 1989

Y1 - 1989

N2 - THE p53 gene has been a constant source of fascination since its discovery nearly a decade ago1,2. Originally considered to be an oncogene, several convergent lines of research have indicated that the wild-type gene product actually functions as a tumour suppressor gene3-9. For example, expression of the neoplastic phenotype is inhibited, rather than promoted, when rat cells are transfected with the murine wild-type p53 gene together with mutant p53 genes and/or other oncogenes3,4. Moreover, in human tumours, the short arm of chromosome 17 is often deleted (reviewed in ref. 10). In colorectal cancers, the smallest common region of deletion is centred at 17pl3.1 (ref. 9); this region harbours the p53 gene, and in two tumours examined in detail, the remaining (non-deleted) p53 alleles were found to contain mutations9. This result was provocative because allelic deletion coupled with mutation of the remaining allele is a theoretical hallmark of tumour-suppressor genes11. In the present report, we have attempted to determine the generality of this observation; that is, whether tumours with allelic deletions of chromosome 17p contain mutant p53 genes in the allele that is retained. Our results suggest that (1) most tumours with such allelic deletions contain p53 point mutations resulting in amino-acid substitutions, (2) such mutations are not confined to tumours with allelic deletion, but also occur in at least some tumours that have retained both parental 17p alleles, and (3) p53 gene mutations are clustered in four 'hot-spots' which exactly coincide with the four most highly conserved regions of the gene. These results suggest that p53 mutations play a role in the development of many common human malignancies.

AB - THE p53 gene has been a constant source of fascination since its discovery nearly a decade ago1,2. Originally considered to be an oncogene, several convergent lines of research have indicated that the wild-type gene product actually functions as a tumour suppressor gene3-9. For example, expression of the neoplastic phenotype is inhibited, rather than promoted, when rat cells are transfected with the murine wild-type p53 gene together with mutant p53 genes and/or other oncogenes3,4. Moreover, in human tumours, the short arm of chromosome 17 is often deleted (reviewed in ref. 10). In colorectal cancers, the smallest common region of deletion is centred at 17pl3.1 (ref. 9); this region harbours the p53 gene, and in two tumours examined in detail, the remaining (non-deleted) p53 alleles were found to contain mutations9. This result was provocative because allelic deletion coupled with mutation of the remaining allele is a theoretical hallmark of tumour-suppressor genes11. In the present report, we have attempted to determine the generality of this observation; that is, whether tumours with allelic deletions of chromosome 17p contain mutant p53 genes in the allele that is retained. Our results suggest that (1) most tumours with such allelic deletions contain p53 point mutations resulting in amino-acid substitutions, (2) such mutations are not confined to tumours with allelic deletion, but also occur in at least some tumours that have retained both parental 17p alleles, and (3) p53 gene mutations are clustered in four 'hot-spots' which exactly coincide with the four most highly conserved regions of the gene. These results suggest that p53 mutations play a role in the development of many common human malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0024387728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024387728&partnerID=8YFLogxK

M3 - Article

C2 - 2531845

AN - SCOPUS:0024387728

VL - 342

SP - 705

EP - 708

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6250

ER -